comparemela.com
Home
Live Updates
Remidios Revolutionary AI on a smartphone for Referable Diabetic Retinopathy (DR) Receives EU MDR Class II Regulatory Approval : comparemela.com
Remidio's Revolutionary AI on a smartphone for Referable Diabetic Retinopathy (DR) Receives EU MDR Class II Regulatory Approval
/PRNewswire/ -- Remidio has received CE mark approval for its Medios AI, to detect Referable DR. This approval closely follows the nod the AI received from...
Related Keywords
Moorfields ,
Ballymena ,
United Kingdom ,
Bangalore ,
Karnataka ,
India ,
London ,
City Of ,
Singapore ,
Divya Rao ,
Shivanthika Murugan ,
Sobha Sivaprasad ,
Singapore Health Sciences Authority ,
Remidio Innovative Solutions ,
Health Sciences Authority ,
Medical Director ,
Consultant Ophthalmologist ,
Moorfields Eye Hospital ,
comparemela.com © 2020. All Rights Reserved.